Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis

Table 9

HPV status and frequency of Fas promoter -670 polymorphism in exfoliated cervical cell samples.

Study group	𝑛	Genotype at Fas promoter -670		OR	95% CI	𝑃f
		AA	GA + GG
High-risk HPV−
Normal	53	15 (28.3%)	38 (71.7%)	1
LSIL	121	36 (29.8%)	85 (70.2%)	0.93	0.44–1.95	.847
HSIL	9	1 (11.1%)	8 (88.9%)	3.16	0.40–25.04	.276
High-risk HPV+
Normal	10	4 (40.0%)	6 (60.0%)	1
LSIL	46	15 (32.6%)	31 (67.4%)	1.38	0.34–5.66	.655
HSIL	40	4 (10.0%)	36 (90.0%)	6.00	1.32–27.37	.021

OR: odds ratio.
CI: confidence interval.